About Viracta Therapeutics, Inc. (VIRX) data
Data as of July 15, 2025.
Viracta Therapeutics, Inc. (VIRX) has 14.25K shares sold short as of the latest FINRA settlement report on July 15, 2025. Short interest has increased by 76.39% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 0.02 days (days to cover).
Frequently asked questions
What is the current short interest in VIRX?
As of the latest FINRA settlement dated July 15, 2025, VIRX had approximately 14,252 shares sold short. Short interest data is reported by FINRA twice per month.
What is the days to cover ratio for VIRX?
Days to cover for VIRX is approximately 0.02 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
Is VIRX a short squeeze candidate?
A squeeze needs shorts that are hard to close. VIRX trades about 793,306 shares a day and would take roughly 0.02 days to unwind current short positions. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.